The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy

Juan Asbun, Francisco J. Villarreal

Resultado de la investigación: Contribución a una revistaReseña científicarevisión exhaustiva

321 Citas (Scopus)


Diabetes has emerged as a major threat to worldwide health. The increasing incidence of diabetes in young individuals is particularly worrisome given that the disease is likely to evolve over a period of years. In 1972, the existence of a diabetic cardiomyopathy was proposed based on the experience with four adult diabetic patients who suffered from congestive heart failure in the absence of discernible coronary artery disease, valvular or congenital heart disease, hypertension, or alcoholism. The exact mechanisms underlying the disease are unknown; however, an important component of the pathological alterations observed in these hearts includes the accumulation of extracellular matrix (ECM) proteins, in particular collagens. The excess deposition of ECM in the heart mirrors what occurs in other organs such as the kidney and peritoneum of diabetics. Mechanisms responsible for these alterations may include the excess production, reduced degradation, and/or chemical modification of ECM proteins. These effects may be the result of direct or indirect actions of high glucose concentrations. This article reviews our state of knowledge on the effects that diabetes-like conditions exert on the cells responsible for ECM production as well as relevant experimental and clinical data. © 2006 by the American College of Cardiology Foundation.
Idioma originalInglés estadounidense
Páginas (desde-hasta)693-700
Número de páginas8
PublicaciónJournal of the American College of Cardiology
EstadoPublicada - 21 feb 2006


Profundice en los temas de investigación de 'The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy'. En conjunto forman una huella única.

Citar esto